Page 2309

7 AAC 105.140. Covered services during declared disaster emergency. (a) Notwithstanding the provisions of 7 AAC 105.610, 7 AAC 110.750, 7 AAC 120.112, 7 AAC 145.400, and 7 AAC 145.410, the department may make adjustments to covered services listed under (b) of this section for the length of a declared disaster emergency if

(1) the governor issues a disaster emergency declaration for the state or a region within the state under AS 26.23.020;

(2) the federal government issues a related disaster declaration or declaration of national emergency for the state or a region within the state under 42 U.S.C. 5121 — 5207 (Stafford Disaster Relief and Emergency Assistance Act) or 50 U.S.C. 1601 — 1651 (National Emergencies Act) and the Secretary of the United States Department of Health and Human Services invokes authority under 42 U.S.C. 1320b-5(b) (sec. 1135(b) of the Social Security Act), with respect to the secretary’s declaration of a public health emergency as described under 42 U.S.C. 1320b-5(b) and (g)(1), to waive or modify certain requirements of titles XVIII, XIX, and XXI of the Social Security Act as a result of the disaster declaration; and

(3) the state either

(A) applies for and receives an approved disaster relief state plan amendment, authorized under 42 U.S.C. 1320b-5, based on the disaster emergency declaration, to make the changes provided for in this section; or

(B) has existing state plan authority from CMS to exercise the provisions of (b) of this section during a declared disaster emergency. (b) If the conditions listed in (a) of this section are met, the department may

(1) for covered outpatient drugs under 7 AAC 105 — 7 AAC 160,

(A) extend the fill duration authorization under 7 AAC 120.112(4) from a 34-day to 68-day supply;

(B) increase the professional dispensing fee rates for in-state claims under 7 AAC 145.410(a)(1) and (2) by up to $2.50;

(C) increase the professional dispensing fee reimbursement frequency under 7 AAC 145.410(a)(1) and (2) to not more than once every 14 days;

(D) allow ingredient reimbursement at actual acquisition cost if the actual acquisition cost is above the lowest determined cost under the formula provided in 7 AAC 145.400 and the provider maintains proof of the actual acquisition cost of the drug consistent with 7 AAC 105.230, substantiated by an unaltered invoice under 7 AAC 105.240;

(E) waive the cost-sharing amounts eligible recipients are required to pay under 7 AAC 105.610(a)(4), if the service is related to screening for, diagnosing, or treating the